{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:17:18Z","timestamp":1790255838975,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["217462"],"award-info":[{"award-number":["217462"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.anai.2024.06.033","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T22:31:26Z","timestamp":1720218686000},"page":"422-429.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Real-world unified airway benefits of mepolizumab"],"prefix":"10.1016","volume":"133","author":[{"given":"Jonathan A.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Packnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn R.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijita","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.anai.2024.06.033_bib0001","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jaip.2023.05.011","article-title":"The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic Therapy","volume":"11","author":"Bachert","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"S2","key":"10.1016\/j.anai.2024.06.033_bib0002","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.5694\/mja18.00196","article-title":"Managing comorbid conditions in severe asthma","volume":"209","author":"Bardin","year":"2018","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.anai.2024.06.033_bib0003","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic Rhinosinusitis with Nasal Polyps and Asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.06.033_bib0004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaci.2021.10.029","article-title":"Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"149","author":"Scadding","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.06.033_bib0005","first-page":"53","article-title":"Asthma and Chronic Rhinosinusitis: Diagnosis and Medical Management","volume":"7","author":"Massoth","year":"2019","journal-title":"Med Sci (Basel)"},{"issue":"9","key":"10.1016\/j.anai.2024.06.033_bib0006","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.anai.2024.06.033_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166833","article-title":"Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.anai.2024.06.033_bib0008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000519228","article-title":"Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis","volume":"183","author":"Wu","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2024.06.033_bib0009","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2023.01.020","article-title":"Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation","volume":"151","author":"Akenroye","year":"2023","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.anai.2024.06.033_bib0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/JAA.S413064","article-title":"Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR","volume":"16","author":"Laidlaw","year":"2023","journal-title":"J Asthma Allergy"},{"issue":"31","key":"10.1016\/j.anai.2024.06.033_bib0011","doi-asserted-by":"crossref","first-page":"e4294","DOI":"10.1097\/MD.0000000000004294","article-title":"The link between chronic rhinosinusitis and asthma: A questionnaire-based study","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.anai.2024.06.033_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100462","article-title":"Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities","volume":"13","author":"Crimi","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2024.06.033_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211009398","article-title":"Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study","volume":"15","author":"Detoraki","year":"2021","journal-title":"Ther Adv Respir Dis"},{"issue":"suppl 65","key":"10.1016\/j.anai.2024.06.033_bib0014","first-page":"PA3727","article-title":"Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study","volume":"58","author":"da Costa Martins","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.anai.2024.06.033_bib0015","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study","volume":"12","author":"Gallo","year":"2022","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.anai.2024.06.033_bib0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2021.05.021","article-title":"Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities","volume":"127","author":"Casale","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2024.06.033_bib0017","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jaip.2020.01.009","article-title":"Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps","volume":"8","author":"Chan","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.06.033_bib0018","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1183\/20734735.0019-2019","article-title":"Evidence for lifestyle interventions in asthma","volume":"15","author":"Stoodley","year":"2019","journal-title":"Breathe (Sheff)"},{"issue":"1","key":"10.1016\/j.anai.2024.06.033_bib0019","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40463-020-00459-w","article-title":"Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review","volume":"49","author":"Wu","year":"2020","journal-title":"J Otolaryngol Head Neck Surg"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624004216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624004216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:23:30Z","timestamp":1778588610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624004216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1081120624004216"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.06.033","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world unified airway benefits of mepolizumab","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}